(0.09%) 5 522.00 points
(0.12%) 39 890 points
(0.21%) 19 792 points
(0.02%) $81.65
(0.46%) $2.82
(-0.33%) $2 336.70
(-0.03%) $29.52
(0.21%) $1 003.90
(0.02%) $0.932
(0.00%) $10.53
(0.01%) $0.788
(-0.85%) $87.25
0.00% $ 0.534
Live Chart Being Loaded With Signals
Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, focuses on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers...
Stats | |
---|---|
Dzisiejszy wolumen | 137 793 |
Średni wolumen | 50 544 |
Kapitalizacja rynkowa | 0.00 |
EPS | $-0.620 ( Q4 | 2023-03-31 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
0 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.0760 (15.09%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-10-18 | Martell Bridget A | Buy | 0 | |
2023-10-18 | Orbach Pini | Buy | 0 | |
2023-10-18 | Golan Roy | Buy | 0 | |
2023-01-19 | Amoon Growth Fund Limited Partnership | Sell | 2 991 473 | Common Stock |
2023-01-19 | Sidransky David | Sell | 12 500 | Stock Option (right to buy) |
INSIDER POWER |
---|
-99.93 |
Last 84 transactions |
Buy: 4 327 382 | Sell: 8 482 924 |
Wolumen Korelacja
Ayala Pharmaceuticals Inc Korelacja
10 Najbardziej pozytywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Ayala Pharmaceuticals Inc Korelacja - Waluta/Towar
Ayala Pharmaceuticals Inc Finanse
Annual | 2022 |
Przychody: | $692 000 |
Zysk brutto: | $90 000.00 (13.01 %) |
EPS: | $-2.46 |
FY | 2022 |
Przychody: | $692 000 |
Zysk brutto: | $90 000.00 (13.01 %) |
EPS: | $-2.46 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $-3.51M (0.00 %) |
EPS: | $-4.69 |
FY | 2020 |
Przychody: | $3.71M |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-3.06 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Ayala Pharmaceuticals Inc
Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, focuses on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers. The company's lead product candidate is AL101, a potent, selective, and injectable small molecule gamma secretase inhibitor (GSI) that is in Phase II clinical trial for the treatment of recurrent/metastatic adenoid cystic carcinoma for patients bearing Notch-activating mutations. It is also involved in developing AL102, a potent, selective, and oral small molecule GSI that is in Phase II/III pivotal study for the treatment of desmoid tumors. Ayala Pharmaceuticals, Inc. has a collaboration agreement with Novartis International Pharmaceutical Limited to develop AL102 for the treatment of multiple myeloma. The company was incorporated in 2017 and is headquartered in Rehovot, Israel.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej